Skip to Main Content

Paper Details

Predicting Gemcitabine Delivery by <sup>18</sup>F-FAC PET in Murine Models of Pancreatic Cancer.
J Nucl Med
5
2021
14C, 14C-, 14C-gemcitabine, 18F-FAC, 2'-deoxy-2'-18F-fluoro--d-arabinofuranosylcytosin, Gemcitabine, KPC (Pdx-, KPC-, KPC-derived tumors, KrasG12D LSL, Mice, PDX, PDX models, PEGPH20, PEGylated recombinant human hyaluronidase, Pancreatic Cancer, Pdx-1 Cre, gemcitabine, human, hyaluronic acid binding protein, mice, mouse, organoid culture, p53R172H, pancreatic cancer, patient, patient-derived xenograft, tumor, tumors
Author NameAffiliation
Milan GrkovskiMemorial Sloan Kettering Cancer Center
Elisa de StanchinaMemorial Sloan Kettering Cancer Center
John L HummMemorial Sloan Kettering Cancer Center
  • 1 - 3

Datasets

Release 1.2